Some antipsychotic polypharmacy protocols may lower the risk for schizophrenia-related rehospitalization in adult patients more so than monotherapy, new research suggests. In a study of more than ...

Credit: Getty Images Dr Erika Ramsdale discusses the risks and complications of polypharmacy in older adults, an increasingly prevalent medication management and public health issue. As the global ...

New to outpatient psychiatry as a third-year resident, my medication intake appointments usually come in one of two flavors: no prior contact with psychiatry or transfers from other clinics with ...

A significant proportion of community-dwelling older adults with dementia take three or more central nervous system (CNS) medications despite guidelines that say to avoid this dangerous practice, new ...

Results of a secondary analysis of a randomized controlled trial emphasize the risks of polypharmacy with regard to prescription and nonprescription medications. Research published in The Oncologist ...

Antipsychotic (AP) polypharmacy is common in psychiatric practice, despite concerns about its risks and questions regarding its effectiveness. A recent study by C. Barbui and colleagues sought to ...

Please provide your email address to receive an email when new articles are posted on . We often encounter patients taking multiple medications, which complicates choosing safe and effective ...

Please provide your email address to receive an email when new articles are posted on . Patients aged 75 to 85 years with more than eight diagnosed diseases or conditions were at the highest risk for ...

The term "polypharmacy" seems to be getting a lot of attention these days. Maybe you heard it referenced in the news in a story about teen mental-health treatment. Perhaps you came across it when ...

Referencing a 2013 Japanese study, 4 Barbui and colleagues suggested that switching from polypharmacy to monotherapy is feasible in a majority of patients with schizophrenia. In the referenced study, ...